However, despite this limitation, the need for additional characterization of brain insulin expression in regard to human health is important, given that intranasal insulin application has been proven to be successful as a treatment not only for Alzheimer’s disease and mild cognitive impairment but for other complications such as cerebral ischemia, traumatic brain injuries, and postoperative delirium [83]. This evidence concerns the gene INS and Alzheimer disease.